Milton Boyer
Chief Executive Officer
A seasoned leader with over 25 years of experience in the pharmaceutical industry, Milton Boyer brings extensive expertise in contract manufacturing for both drug substances and sterile drug products.
Milton has served in technical, commercial and executive roles in the pharmaceutical industry for more than 25 years, with a focus in contract manufacturing for both drug substances and sterile drug products. For the last 15 years, he has been immersed in the complexities of sterile drug product manufacturing, most recently as the Chief Executive Officer of SCA Pharmaceuticals in Arkansas. He was also the Head of Drug Product Manufacturing for AMRI (now Curia) in New York and Chief Executive Officer for sterile fill-finish contract manufacturer Oso BioPharmaceuticals, establishing the business after Altaris carved out Catalent’s site in New Mexico.
Active in trade groups and educational institutions supporting the pharmaceutical and biopharmaceutical industry, Milton has served on the board of directors and was President of the Drug, Chemical & Allied Trades Association (DCAT). He has also served on the external advisory board for the University of New Mexico’s chemistry and chemical biology department and been an active member of multiple professional organizations, including the American Association of Pharmaceutical Scientists, the Parenteral Drug Association, and the Society of Chemical Manufacturers and Affiliates.
Milton earned a B.S. in chemistry/physics from Hardin-Simmons University and an M.S. in biochemistry from Texas Tech University.
How can Milton help you?
-
His 15+ years in sterile drug product manufacturing ensures Kindeva can offer you deep expertise in this critical area
-
Milton’s extensive background in contract manufacturing for both drug substances and sterile drug products means he understands your unique needs and challenges
-
His experience as CEO of multiple pharmaceutical companies translates to strong operational leadership, ensuring efficiency and reliability for your projects
-
Milton’s active involvement in trade groups like DCAT and advisory boards gives him valuable industry connections and insights to benefit you
-
His combined background and extensive business experience allows him to effectively bridge the gap between your scientific innovation and commercial success
See who else is in the team
Discover a team with technical expertise and a passion for purpose, dedicated to helping you manufacture more tomorrows and transform the future of drug delivery.
